Product Information

THYROID 60 MG TABLET is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.6655 per EA under NDC 69680016700. Its NADAC has been published 75 times since Mar 19, 2025.

THYROID 60 MG TABLET

THYROID
$0.6655per EA

Strength

60 mg/1

NDC

69680016700

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

THYROID

Approval Type

Unapproved

On Market Since

11/22/2024

Price Statistics

The NADAC for THYROID 60 MG TABLET has been published 75 times since Mar 19, 2025, and over the history we have for it it has declined 3.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6655 per EA
All-time high$0.6886 (Apr 16, 2025)
All-time low$0.6619 (Mar 18, 2026)
52-week high$0.6762
52-week low$0.6619
Median price$0.6686
Average price$0.6721
Largest weekly change-1.0% (Jan 21, 2026)
Weeks tracked75
Tracking sinceMar 19, 2025

Price History

1W

+0.3%

1M

+0.3%

3M

+0.1%

6M

+0.0%

1Y

-1.6%

3Y

N/A

5Y

N/A

All

-3.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the THYROID market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of THYROID 60 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for THYROID 60 MG TABLET, manufactured by Vitruvias Therapeutics Inc., is $0.6655 per EA (NDC 69680016700), effective Aug 19, 2026.

How has the price of THYROID 60 MG TABLET changed over time?

Over the history we have for it, the NADAC for THYROID 60 MG TABLET has declined 3.4%. It has been tracked across 75 weekly CMS publications since Mar 19, 2025.

What are the highest and lowest recorded NADAC prices for THYROID 60 MG TABLET?

Since Mar 19, 2025, the NADAC for THYROID 60 MG TABLET has ranged from a low of $0.6619 (Mar 18, 2026) to a high of $0.6886 (Apr 16, 2025), with a median of $0.6686 per EA.

Are there cheaper alternatives to THYROID 60 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of THYROID 60 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures THYROID 60 MG TABLET?

THYROID 60 MG TABLET (NDC 69680016700) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.